Page last updated: 2024-08-16

troglitazone and bilirubin

troglitazone has been researched along with bilirubin in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	8 (88.89)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fujita, Y; Kuwao, S; Saigenji, K; Shibuya, A; Takahashi, H; Takeuchi, H; Watanabe, M	1
Ikeda, T; Konno, K; Takasaki, W; Yoshigae, Y	1
Altrogge, D; Burliegh, J; Kindt, E; Kostrubsky, VE; Peter, G; Rogers, K; Sinz, MW; Vore, M	1
Lewis, JH	1
Temple, R	1
Kaplowitz, N	1
Senior, JR	1
Akiyama, Y; Koh, H; Yui, K	1

Trials

1 trial(s) available for troglitazone and bilirubin

Article	Year
Effect of troglitazone on serum gamma-glutamyltransferase activity and plasma t-PA/PAI-1 complex in type 2 diabetic patients. Arzneimittel-Forschung, 2006, Volume: 56, Issue:4 Topics: Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Bilirubin; Blood Glucose; C-Reactive Protein; Chromans; Diabetes Mellitus, Type 2; Female; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Thiazolidinediones; Tissue Plasminogen Activator; Troglitazone	2006

Article

Year

Effect of troglitazone on serum gamma-glutamyltransferase activity and plasma t-PA/PAI-1 complex in type 2 diabetic patients.

Arzneimittel-Forschung, 2006, Volume: 56, Issue:4

Topics: Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Bilirubin; Blood Glucose; C-Reactive Protein; Chromans; Diabetes Mellitus, Type 2; Female; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Thiazolidinediones; Tissue Plasminogen Activator; Troglitazone

2006

Other Studies

8 other study(ies) available for troglitazone and bilirubin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
An autopsy case of troglitazone-induced fulminant hepatitis. Diabetes care, 1998, Volume: 21, Issue:12 Topics: Alanine Transaminase; Autopsy; Bilirubin; Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Hepatic Encephalopathy; Humans; Hypoglycemic Agents; Liver; Male; Middle Aged; Prothrombin Time; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone	1998
Characterization of UDP-glucuronosyltransferases (UGTS) involved in the metabolism of troglitazone in rats and humans. The Journal of toxicological sciences, 2000, Volume: 25, Issue:5 Topics: Animals; Bilirubin; Chromans; Glucuronides; Glucuronosyltransferase; Humans; Hypoglycemic Agents; Isoenzymes; Male; Microsomes, Liver; Polymorphism, Genetic; Rats; Rats, Gunn; Rats, Wistar; Thiazoles; Thiazolidinediones; Troglitazone	2000
The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats. Drug metabolism and disposition: the biological fate of chemicals, 2001, Volume: 29, Issue:12 Topics: Animals; Animals, Genetically Modified; Area Under Curve; Bile; Bile Acids and Salts; Bilirubin; Biotransformation; Cholestasis; Chromans; Glucuronides; Hypoglycemic Agents; Male; Organic Anion Transporters; Quinones; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Tissue Distribution; Troglitazone	2001
'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Alanine Transaminase; Anticoagulants; Azetidines; Benzylamines; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Jaundice; Liver; Liver Failure, Acute; Pharmacoepidemiology; Predictive Value of Tests; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006
Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006
Rules and laws of drug hepatotoxicity. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006
How can 'Hy's law' help the clinician? Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006